These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1511329)

  • 41. Acetylcholinesterase-containing neurons in the neostriatum and substantia nigra revealed after punctate intracerebral injection of di-isopropylfluorophosphate.
    Butcher LL; Bilezikjian L
    Eur J Pharmacol; 1975 Nov; 34(1):115-25. PubMed ID: 1234757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Demonstration of a pallido-nigral projection innervating dopaminergic neurons.
    Hattori T; Fibiger HC; McGeer PL
    J Comp Neurol; 1975 Aug; 162(4):487-504. PubMed ID: 50334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis.
    Freestone PS; Chung KK; Guatteo E; Mercuri NB; Nicholson LF; Lipski J
    Eur J Neurosci; 2009 Nov; 30(10):1849-59. PubMed ID: 19912331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Connexin mRNA expression in single dopaminergic neurons of substantia nigra pars compacta.
    Vandecasteele M; Glowinski J; Venance L
    Neurosci Res; 2006 Dec; 56(4):419-26. PubMed ID: 17014920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two types of neurons in the substantia nigra pars compacta studied in a slice preparation.
    Matsuda Y; Fujimura K; Yoshida S
    Neurosci Res; 1987 Dec; 5(2):172-9. PubMed ID: 3431756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methamidophos transiently inhibits neuronal nicotinic receptors of rat substantia nigra dopaminergic neurons via open channel block.
    Di Angelantonio S; Bernardi G; Mercuri NB
    Neurosci Lett; 2004 Oct; 369(3):208-13. PubMed ID: 15464266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrophysiological effects of amineptine on neurones of the rat substantia nigra pars compacta: evidence for an inhibition of the dopamine uptake system.
    Mercuri NB; Stratta F; Calabresi P; Bernardi G
    Br J Pharmacol; 1991 Nov; 104(3):700-4. PubMed ID: 1797329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
    Iribe Y; Moore K; Pang KC; Tepper JM
    J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excitation of substantia nigra pars compacta neurones by 5-hydroxy-tryptamine in-vitro.
    Nedergaard S; Flatman JA; Engberg I
    Neuroreport; 1991 Jun; 2(6):329-32. PubMed ID: 1717045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential spread of anoxic depolarization contributes to the pattern of neuronal injury after oxygen and glucose deprivation (OGD) in the Substantia Nigra in rat brain slices.
    Karunasinghe RN; Grey AC; Telang R; Vlajkovic SM; Lipski J
    Neuroscience; 2017 Jan; 340():359-372. PubMed ID: 27826106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acetylcholinesterase has a non-cholinergic neuromodulatory action in the guinea-pig substantia nigra.
    Last AT; Greenfield SA
    Exp Brain Res; 1987; 67(2):445-8. PubMed ID: 3040458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological localization of distinct calcium potentials at selective somatodendritic sites in the substantia nigra.
    Hounsgaard J; Nedergaard S; Greenfield SA
    Neuroscience; 1992 Oct; 50(3):513-8. PubMed ID: 1331866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake of acetylcholinesterase by neurons in the substantia nigra.
    Dickie BG; Budd TC; Vaux D; Greenfield SA
    Eur J Neurosci; 1995 Mar; 7(3):351-7. PubMed ID: 7773434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a Bioactive Peptide T14 in the Human and Rodent Substantia Nigra: Implications for Neurodegenerative Disease.
    Greenfield SA; Ferrati G; Coen CW; Vadisiute A; Molnár Z; Garcia-Rates S; Frautschy S; Cole GM
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Release of acetylcholinesterase within the guinea-pig substantia nigra: effects of 5-hydroxytryptamine and amphetamine.
    Taylor SJ; Bartlett MJ; Greenfield SA
    Neuropharmacology; 1988 May; 27(5):507-14. PubMed ID: 3260662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A noncholinergic action of acetylcholinesterase (AChE) in the brain: from neuronal secretion to the generation of movement.
    Greenfield SA
    Cell Mol Neurobiol; 1991 Feb; 11(1):55-77. PubMed ID: 2013059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockade of dopamine storage, but not of dopamine synthesis, prevents activation of a tolbutamide-sensitive K+ channel in the guinea-pig substantia nigra.
    McGroarty A; Greenfield SA
    Exp Brain Res; 1996 Aug; 110(3):360-6. PubMed ID: 8871095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of acetylcholinesterase to the substantia nigra induces stereotypy in rats.
    Weston J; Greenfield SA
    Behav Brain Res; 1985; 18(1):71-4. PubMed ID: 3911982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant acetylcholinesterase has behavioural effects in the rat substantia nigra not attributable to its enzymatic activity.
    Hawkins CA; Greenfield SA
    Neurosci Lett; 1995 Sep; 197(3):203-6. PubMed ID: 8552299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.